Embio Diagnostics is a biotechnology company headquartered in Nicosia, Cyprus, that designs and develops portable, biosensor-based digital devices for rapid testing across various global industries.
Subscribe to see Embio Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Embio Diagnostics is a diagnostic equipment company headquartered in Cyprus. It has raised at least $2.8M across the 2 funding rounds on record. Its most recent funding round, Grant, raised $1.6M in December 2021. Xcout tracks 7 named people at Embio Diagnostics, including Lina Kourtella (COO).
1 more named person on record for Embio Diagnostics, with roles, board committees and tenure — see the full roster →
At least $2.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $1.6M | 3 named | |
| Seed | $1.2M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Embio Diagnostics's closest competitors — see the full list of competitors and alternatives →
Apex Biotechnology Corp. is a Taiwanese firm that specializes in the global development, manufacturing, and distribution of medical devices designed for home use, all powered by sophisticated biosensor technology. Their comprehensive product lineup features a variety of personal health monitoring systems, including those for tracking blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1c, and ketone levels. In addition, the company provides self-testing solutions for coagulation and multi-parameter analysis, alongside advanced hemoglobin screening systems. Beyond patient diagnostics, Apex Biotech also offers systems for detecting pesticide residues. The company further extends its services to include digital care management and telehealth platforms. Established in 1997, Apex Biotechnology Corp. operates from its headquarters located in Hsinchu City, Taiwan.
Spartan Bioscience was a Canadian biotechnology and diagnostics company based in Ottawa that developed portable, rapid PCR-based DNA analyzers and associated test kits. Its products were intended for healthcare providers, laboratories, and other organizations needing decentralized testing for infectious diseases and genetic targets, including COVID-19.
RightBio Metrics Inc. is a healthcare and life sciences company headquartered in Brecksville, Ohio, that develops rapid diagnostic measurement tools and medical devices.
Biohit Oyj is a Finnish biotechnology company that develops and markets products and services for medical research, early diagnosis, and disease prevention. Its offerings include gastrointestinal diagnostic tests, laboratory equipment, monoclonal antibodies, and health-related consumer products such as the Acetium series.
NanoSynex is a medical technology company that develops rapid diagnostic systems to test for antibiotic resistance and provide personalized antibiotic treatments. The company serves the healthcare sector by aiming to speed up bacterial diagnosis, improve testing quality, and combat the antibiotics crisis.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.